|
QuintilesIMS Real-World Insights Bibliography
| Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment |
| Author(s): Rockberg J1, Jørgensen L1, Taylor B2, Sobocki P1, Johansson G3. |
| Affiliations(s): 1 QuintilesIMS, Solna, Sweden.
2 Amgen Inc, Thousand Oaks, CA, USA.
3 Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. |
| Publication(s): Prev Med Rep |
| Document Type(s): Article |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2017 |
|
L:
A: |
English
Real World Evidence |
|
 |
| |
| |
| Extent and impact of late vs early stage COPD diagnosis in a Swedish cohort: The ARCTIC study. |
| Author(s): Larsson K, Janson C, Ställberg B, Lisspers K, Olsson P, Kostikas K, Uhde M, Jorgensen L, Gutzwiller F S, Johansson G. |
| Affiliations(s): |
| Publication(s): Nordic Lung Congress 2017, 10-12 May Visby Sweden |
| Document Type(s): Abstract |
| Countries: Sweden |
C:
Y: |
Respiratory disease
2017 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| Comorbidities in Swedish COPD and non-COPD patients: ARCTIC study. |
| Author(s): Ställberg B, Janson C, Larsson K, Johansson G, Kostikas K, Gruenberger J-B, Gutzwiller F S, Jorgensen L, Uhde M, Lisspers K. |
| Affiliations(s): |
| Publication(s): Nordic Lung Congress 2017, 10-12 May, Visby Sweden |
| Document Type(s): |
| Countries: Sweden |
C:
Y: |
Respiratory disease
2017 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. |
| Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. |
| Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
2Centre for Observational Research, Amgen Ltd, Uxbridge, UK.
3IMS Health Sweden, Stockholm, Sweden.
|
| Publication(s): Clinical Epidemiology |
| Document Type(s): Article |
| Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Literature Review |
|
|
| |
| |
| Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden |
| Author(s): Lind M1,2, Matsson PO3, Linder R4, Svenningsson I5, Jørgensen L6, Ploug UJ7, Gydesen H7, Dorkhan M8, Larsen S8, Johansson G9. |
| Affiliations(s): 1Department of Medicine, NU-Hospital Group, Trollhättan/Uddevalla, Sweden. lind.marcus@telia.com.
2Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. lind.marcus@telia.com.
3Domnarvet VC, Borlänge, Sweden.
4Pygargus, Stockholm, Sweden.
5Research and Development Unit, Primary Health Care, Närhälsan, Vänersborg, Sweden.
6IMS Health, Stockholm, Sweden.
7Novo Nordisk A/S, Søborg, Denmark.
8Novo Nordisk Scandinavia AB, Malmö, Sweden.
9Department of Caring Sciences and Family Medicine, Uppsala University, Uppsala, Sweden. |
| Publication(s): Diabetes Ther |
| Document Type(s): Article |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Diabetes
2016 |
|
L:
A: |
English
Retrospective cohort analysis |
|
|
| |
| |
| Population-based study of giant cell tumor of bone in Sweden (1983-2011). |
| Author(s): Amelio JM1, Rockberg J2, Hernandez RK3, Sobocki P4, Stryker S5, Bach BA3, Engellau J6, Liede A5 |
| Affiliations(s): 1Amgen Ltd. Uxbridge, UK. Electronic address: justyna.amelio@amgen.com.
2Pygargus/IMS Health, Stockholm, Sweden.
3Amgen Inc. Thousand Oaks, CA, USA.
4Pygargus/IMS Health, Stockholm, Sweden; Karolinska Institutet, Stockholm, Sweden.
5Amgen Inc. South San Francisco, CA, USA.
6Lund University, Lund, Sweden. |
| Publication(s): Cancer Epidemiol |
| Document Type(s): Article |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| Lipid-lowering treatment patterns in patients with new cardiovascular events - estimates from population-based register data in Sweden. |
| Author(s): Hallberg S1, Banefelt J1, Fox KM2, Mesterton J1,3, Johansson G4, Levin LÅ5, Sobocki P3,6, Gandra SR7. |
| Affiliations(s): 1Quantify Research, Stockholm, Sweden.
2Strategic Healthcare Solutions, LLC, Baltimore, MD, USA.
3LIME/Medical Management Centre, Karolinska Institute, Stockholm, Sweden.
4Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
5Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
6IMS Health, Stockholm, Sweden.
7Amgen Inc., Thousand Oaks, CA, United States. |
| Publication(s): Int J Clin Pract |
| Document Type(s): Article |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Epidemiological study |
|
|
| |
| |
| Exposure to heart failure treatments in newly diagnosed patients in Sweden |
| Author(s): G Wikstrom1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, J Stalhammar7, |
| Affiliations(s): 1Uppsala University, Institute for Medical Sciences - Uppsala - Sweden, 2Umea University, Department of Public Health and Clinical Medicine - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden |
| Publication(s): European Journal of Heart Failure, 2016, Vol. 18, 48-48 p. |
| Document Type(s): Abstract |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| Dosing of heart failure treatments in newly diagnosed unselected patients in Sweden: compliance with European society of cardiology guidelines |
| Author(s): G Wikstrom1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, J Stalhammar7 |
| Affiliations(s): 1Uppsala University, Institute for Medical Sciences - Uppsala - Sweden, 2Umea University, Research Unit, Medicine and Geriatric, Skellefteå County Hospital, Department of Public Health - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden |
| Publication(s): European Journal of Heart Failure |
| Document Type(s): Abstract |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| Recent trends in diagnostic work-up among unselected patients newly diagnosed with heart failure: a Swedish population-based study |
| Author(s): J Stalhammar1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, G Wikstrom7 |
| Affiliations(s): 1Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden, 2Umea University, Research Unit, Medicine and Geriatric, Skellefteå County Hospital, Department of Public Health - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Institute for Medical Sciences - Uppsala - Sweden |
| Publication(s): European Journal of Heart Failure |
| Document Type(s): Abstract |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
 1 of 13 
|
|
